Developing Biomarkers Incorporating High Throughput RNA, DNA, Small RNA Sequencing and Protein Expression in Inflammatory Bowel Disease Using Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples

AFFECTION_STATUS - Affection status of the subject for inflammatory bowel disease (IBD) (phv00525885.v1.p1)
FAMILY_HISTORY - Family history of inflammatory bowel disease (phv00525892.v1.p1)

ANALYTE_TYPE - Analyte type of sample (phv00525899.v1.p1)
B_MONTREAL - Montreal behavior at follow-up (phv00525889.v1.p1)
BATCH - Batch number (phv00525888.v1.p1)
BODY_SITE - Body site from which sample was collected (phv00525898.v1.p1)
CONSENT - Consent group as determined by DAC (phv00525880.v1.p1)
GEO_ACCESSION - GEO accession ID (GSM#) (phv00525896.v1.p1)
IS_TUMOR - Tumor status of sample (phv00525900.v1.p1)
LOCATION_MONTREAL - Montreal Location Classification (phv00525887.v1.p1)
PERIANAL_DISEASE - Presence of perianal disease at diagnosis (phv00525890.v1.p1)
RECTOSIGMOID_INVOLVEMENT - Involvement of rectosigmoid at diagnosis (phv00525891.v1.p1)
REMISSION - Period of remission during follow-up (6mo steroid-free interval) (phv00525894.v1.p1)
SAMPLE_ID - Sample ID (phv00525897.v1.p1)
SAMPLE_ID - Sample ID (phv00525882.v1.p1)
SAMPLE_ID - Sample ID (phv00525895.v1.p1)
SUBJECT_ID - Subject ID (phv00525883.v1.p1)
SUBJECT_ID - Subject ID (phv00525878.v1.p1)
SUBJECT_ID - Subject ID (phv00525881.v1.p1)
SURGERY - Progression to surgery at follow-up (phv00525893.v1.p1)